Pra Health Sciences Clinical Development Re-imagined

By Author: Icons Edge
Total Articles: 8
Comment this article

With a mission dedicated to redefining the future of clinical development, PRA Health Sciences is leading the way in transforming and disrupting both clinical development and healthcare delivery. They recognize that the drug development industry is at cross-roads and that innovative approaches are needed to bring new therapies to more patients more efficiently and cost effectively.

PRA is a full-service global contract research organization, providing a broad range of product development and data solution services to pharmaceutical and biotechnology companies around the world. PRA’s integrated services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting.

The company has been taking a patientcentered approach and incorporating the patient voice into drug development. “We are engaging patients as consumers and integrating how we connect and deliver clinical trials to patients via the technology they use in their everyday lives, such as mobile smart devices,” says Kent Thoelke, EVP and Chief Scientific Officer at PRA. “We are exploring ways ...
... to virtualize trials to make them more accessible, particularly for hard to reach populations such as rare disease patients.”

In one case study, a renowned pharmaceutical client required a mobile technology solution to collect safety and effectiveness data on a groundbreaking treatment for an ultra-rare disease in a global gene therapy prospective registry. The client needed a multilingual technology platform and the solution would need to evolve with changing mobile devices’ operating systems over the study’s 15-year life cycle to remain updated, functional, and accessible. PRA’s executive medical director worked with the sponsor’s clinical and data management teams to create a flexible mobile platform for patients, parents, and caregivers. Their strategic planning and teamwork resulted in timely delivery of an efficient mobile solution for enrollment, engagement, and electronic data capture (EDC) in a single, user-friendly platform.

By utilizing their virtual and connected e n v i r o n m e n t , access to clinical trials becomes democratized and clinical research as a care option (CRACO) has the opportunity to become a standard option as opposed to an exception. By creating an environment where CRACO is standard, the concept of contract research evolves into a more focused healthcare delivery partnership that is inclusive of clinical trials and clinical research.

Read More: https://www.iconsedge.com/ranking/pra-health-sciences-clinical-development-reimagined-cid-31-mid-4.html

#PRAHealthSciences #globaltechnologyindustry #IconsEdgeMagazine #globalbusinessmagazine #BestEntrepreneursconference